Real-World Evidence Studies of XPHOZAH(R) (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Real-World Evidence Studies of XPHOZAH(R) (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week GlobeNewswire November 07, 2025 WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that […]

Delisting of Securities from The Nasdaq Stock Market

Delisting of Securities from The Nasdaq Stock Market GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.'s common stock was suspended on April 15, 2025 and has not traded on Nasdaq since

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 07, 2025 BRISBANE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 4, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards GlobeNewswire November 07, 2025 WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced that

Arhaus Opens Its First Montana Showroom in Bozeman

Arhaus Opens Its First Montana Showroom in Bozeman The artisan-crafted furnishings brand debuts its first Montana location at Bozeman's Gallatin Crossing GlobeNewswire November 07, 2025 BOSTON HEIGHTS, Ohio, Nov. 07, 2025 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, today announced the opening of its

BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire November 07, 2025 MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing

Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings

Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings GlobeNewswire November 07, 2025 ZUG, Switzerland, Nov. 07, 2025 (GLOBE NEWSWIRE) — Lithium Argentina AG (“Lithium Argentina” or the “Company“) (TSX: LAR) (NYSE: LAR) will release its third quarter 2025 earnings results before market open on Monday, November 10, 2025. In conjunction,

Freedom Holding Corp. to Build $2B Sovereign AI Hub in Kazakhstan Powered by NVIDIA

Freedom Holding Corp. (NASDAQ: FRHC), a financial services and technology company has signed an agreement with the Ministry of Artificial Intelligence and Digital Development of the Republic of Kazakhstan to develop a $2 billion Sovereign AI Hub in Kazakhstan. The hub will be operated by Freedom Holding Corp. and powered by sovereign exascale NVIDIA AI

Calumet to Attend Bank of America Conference

Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today that it plans to attend the Bank of America Global Energy Conference in Houston on Tuesday, November 11th and will hold one-on-one investor meetings at the conference. About Calumet Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to

Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2025

(TSX:SEC), MONTREAL, Nov. 07, 2025 (GLOBE NEWSWIRE) — Senvest Capital Inc. today reported net income attributable to common shareholders of $172.8 million or $70.98 per share for the three months ended September 30, 2025. This compares to a net income attributable to common shareholders of $170.5 million or 69.24 per share for the same period

Scroll to Top